Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16809903rdf:typepubmed:Citationlld:pubmed
pubmed-article:16809903lifeskim:mentionsumls-concept:C2349001lld:lifeskim
pubmed-article:16809903lifeskim:mentionsumls-concept:C0023676lld:lifeskim
pubmed-article:16809903lifeskim:mentionsumls-concept:C0028754lld:lifeskim
pubmed-article:16809903lifeskim:mentionsumls-concept:C0681850lld:lifeskim
pubmed-article:16809903lifeskim:mentionsumls-concept:C1706203lld:lifeskim
pubmed-article:16809903lifeskim:mentionsumls-concept:C2697811lld:lifeskim
pubmed-article:16809903lifeskim:mentionsumls-concept:C0060095lld:lifeskim
pubmed-article:16809903lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:16809903lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:16809903lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:16809903lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:16809903lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:16809903lifeskim:mentionsumls-concept:C1550501lld:lifeskim
pubmed-article:16809903lifeskim:mentionsumls-concept:C1882417lld:lifeskim
pubmed-article:16809903lifeskim:mentionsumls-concept:C1554963lld:lifeskim
pubmed-article:16809903pubmed:issue4lld:pubmed
pubmed-article:16809903pubmed:dateCreated2006-8-4lld:pubmed
pubmed-article:16809903pubmed:abstractTextIt has been found that the expression of fatty acid binding protein 2 (FABP2) mRNA is under dietary control. A G-to-A transition at codon 54 of FABP2 results in an amino acid substitution (from Ala 54 to Thr 54). This polymorphism was associated with high insulin resistance and high fasting insulin concentrations. The aim of our study was to investigate the influence of Thr54 polymorphism in the FABP2 protein on the response to a lifestyle modification (Mediterranean hypocaloric diet and exercise) in obese patients.lld:pubmed
pubmed-article:16809903pubmed:languageenglld:pubmed
pubmed-article:16809903pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16809903pubmed:citationSubsetIMlld:pubmed
pubmed-article:16809903pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16809903pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16809903pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16809903pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16809903pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16809903pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16809903pubmed:statusMEDLINElld:pubmed
pubmed-article:16809903pubmed:issn0250-6807lld:pubmed
pubmed-article:16809903pubmed:authorpubmed-author:AllenVVlld:pubmed
pubmed-article:16809903pubmed:authorpubmed-author:CondeRRlld:pubmed
pubmed-article:16809903pubmed:authorpubmed-author:de LuisD ADAlld:pubmed
pubmed-article:16809903pubmed:authorpubmed-author:IzaolaOOlld:pubmed
pubmed-article:16809903pubmed:authorpubmed-author:SagradoM...lld:pubmed
pubmed-article:16809903pubmed:copyrightInfoCopyright 2006 S. Karger AG, Basel.lld:pubmed
pubmed-article:16809903pubmed:issnTypePrintlld:pubmed
pubmed-article:16809903pubmed:volume50lld:pubmed
pubmed-article:16809903pubmed:ownerNLMlld:pubmed
pubmed-article:16809903pubmed:authorsCompleteYlld:pubmed
pubmed-article:16809903pubmed:pagination354-60lld:pubmed
pubmed-article:16809903pubmed:meshHeadingpubmed-meshheading:16809903...lld:pubmed
pubmed-article:16809903pubmed:meshHeadingpubmed-meshheading:16809903...lld:pubmed
pubmed-article:16809903pubmed:meshHeadingpubmed-meshheading:16809903...lld:pubmed
pubmed-article:16809903pubmed:meshHeadingpubmed-meshheading:16809903...lld:pubmed
pubmed-article:16809903pubmed:meshHeadingpubmed-meshheading:16809903...lld:pubmed
pubmed-article:16809903pubmed:meshHeadingpubmed-meshheading:16809903...lld:pubmed
pubmed-article:16809903pubmed:meshHeadingpubmed-meshheading:16809903...lld:pubmed
pubmed-article:16809903pubmed:meshHeadingpubmed-meshheading:16809903...lld:pubmed
pubmed-article:16809903pubmed:meshHeadingpubmed-meshheading:16809903...lld:pubmed
pubmed-article:16809903pubmed:meshHeadingpubmed-meshheading:16809903...lld:pubmed
pubmed-article:16809903pubmed:meshHeadingpubmed-meshheading:16809903...lld:pubmed
pubmed-article:16809903pubmed:meshHeadingpubmed-meshheading:16809903...lld:pubmed
pubmed-article:16809903pubmed:meshHeadingpubmed-meshheading:16809903...lld:pubmed
pubmed-article:16809903pubmed:meshHeadingpubmed-meshheading:16809903...lld:pubmed
pubmed-article:16809903pubmed:meshHeadingpubmed-meshheading:16809903...lld:pubmed
pubmed-article:16809903pubmed:meshHeadingpubmed-meshheading:16809903...lld:pubmed
pubmed-article:16809903pubmed:meshHeadingpubmed-meshheading:16809903...lld:pubmed
pubmed-article:16809903pubmed:meshHeadingpubmed-meshheading:16809903...lld:pubmed
pubmed-article:16809903pubmed:meshHeadingpubmed-meshheading:16809903...lld:pubmed
pubmed-article:16809903pubmed:meshHeadingpubmed-meshheading:16809903...lld:pubmed
pubmed-article:16809903pubmed:meshHeadingpubmed-meshheading:16809903...lld:pubmed
pubmed-article:16809903pubmed:year2006lld:pubmed
pubmed-article:16809903pubmed:articleTitleInfluence of ALA54THR polymorphism of fatty acid binding protein 2 on lifestyle modification response in obese subjects.lld:pubmed
pubmed-article:16809903pubmed:affiliationInstitute of Endocrinology and Nutrition, Medical School and Unit of Investigation, Hospital Rio Hortega, University of Valladolid, Valladolid, Spain. dadluis@yahoo.eslld:pubmed
pubmed-article:16809903pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:2169entrezgene:pubmedpubmed-article:16809903lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16809903lld:entrezgene